Transcat, Inc. Forecasted to Earn Q1 2025 Earnings of $0.35 Per Share (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for Transcat in a research note issued on Wednesday, May 22nd. HC Wainwright analyst S. Buck anticipates that the scientific and technical instruments company will post earnings of $0.35 per share for the quarter. HC Wainwright has a “Buy” rating and a $156.00 price target on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.98 per share. HC Wainwright also issued estimates for Transcat’s Q2 2025 earnings at $0.43 EPS, Q3 2025 earnings at $0.44 EPS and Q4 2025 earnings at $0.65 EPS.

Several other brokerages have also issued reports on TRNS. Oppenheimer lifted their target price on shares of Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday. Northland Capmk lowered shares of Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st. Finally, Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $134.50.

Transcat Price Performance

Shares of NASDAQ:TRNS opened at $142.18 on Thursday. Transcat has a 12 month low of $81.26 and a 12 month high of $147.00. The stock has a market cap of $1.26 billion, a P/E ratio of 89.42 and a beta of 0.61. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average of $113.21 and a 200 day moving average of $105.94.

Insider Transactions at Transcat

In other news, CEO Lee D. Rudow sold 2,373 shares of the business’s stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the completion of the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at approximately $11,553,953.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Lee D. Rudow sold 2,373 shares of the company’s stock in a transaction on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at approximately $11,553,953.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Lee D. Rudow sold 3,343 shares of the company’s stock in a transaction on Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the sale, the chief executive officer now owns 103,692 shares of the company’s stock, valued at $12,870,251.04. The disclosure for this sale can be found here. Company insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Transcat

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Rice Hall James & Associates LLC raised its holdings in Transcat by 0.4% during the 1st quarter. Rice Hall James & Associates LLC now owns 27,472 shares of the scientific and technical instruments company’s stock valued at $3,061,000 after buying an additional 96 shares during the last quarter. Diversified Trust Co increased its position in Transcat by 4.3% during the 4th quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock valued at $266,000 after purchasing an additional 100 shares during the period. White Pine Capital LLC increased its position in Transcat by 1.5% during the 3rd quarter. White Pine Capital LLC now owns 9,985 shares of the scientific and technical instruments company’s stock valued at $978,000 after purchasing an additional 144 shares during the period. Commonwealth Equity Services LLC increased its position in Transcat by 4.2% during the 3rd quarter. Commonwealth Equity Services LLC now owns 4,377 shares of the scientific and technical instruments company’s stock valued at $429,000 after purchasing an additional 175 shares during the period. Finally, Swiss National Bank increased its position in Transcat by 1.2% during the 3rd quarter. Swiss National Bank now owns 16,815 shares of the scientific and technical instruments company’s stock valued at $1,647,000 after purchasing an additional 200 shares during the period. 98.34% of the stock is currently owned by institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.